Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Document › Details

Abzena Ltd.. (1/20/22). "Press Release: Abzena Appoints Jim Kennamer as SVP and Site Head of North Carolina". Cambridge & San Diego, CA.

Organisation Organisation Abzena (Group)
Products Product reagents (bio/biochemical)
  Product 2 contract manufacturing (biologicals)
     


Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Jim Kennamer as Senior Vice President and Site Head of North Carolina.

Jim has a Bachelor of Science Degree in Biochemistry from Oklahoma State University in Stillwater, Oklahoma and a Doctor of Philosophy, Biochemistry also from Oklahoma State University.

With over 30 years’ experience in the Pharmaceutical industry, Jim has held various positions with increasing levels of responsibilities at Boehringer Mannheim Biochemical, Roche Molecular Biochemicals, Diosynth, Strategene, and Talecris Biotherapeutics/Grifols Therapeutics. For the past six years, he has been the Vice President of Global Manufacturing Operations for Immucor in Norcross Georgia.

Jim has deep experience with manufacturing operations and processes, particularly in process improvements. He has driven regulatory compliance and audit readiness for multiple regulatory agencies established complex supply agreements and has driven LEAN and right-first-time operations throughout his organizations. Jim previously sat on the North Carolina State University Biotechnology Training and Education Center (BTEC) Advisory Board.


Notes to editors


About Abzena

Abzena is a leading partner research organization that offers discovery, design, development and cGMP manufacture of biologics, bioconjugates, and complex or highly potent small molecules to the global biopharmaceutical industry. From its facilities in the UK and US, the company provides its customers with concept to clinic solutions. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.

   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Abzena (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top